Stock Code: 300765 Stock Abbreviation: CStone Pharma Announcement No.: 2026-055
CStone Pharma Co., Ltd. Announcement on the Progress of Issuing H Shares and Listing
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false representations, misleading statements, or material omissions.
CStone Pharma Co., Ltd. (hereinafter referred to as the "Company") is proceeding with its application to list its shares overseas (H shares) and to be listed on the Main Board of The Stock Exchange of Hong Kong Limited (hereinafter referred to as the "Hong Kong Stock Exchange") (hereinafter referred to as the "Proposed Offering and Listing"). The Company submitted its application for the Proposed Offering and Listing to the Hong Kong Stock Exchange on December 10, 2025, and published the application materials for the Proposed Offering and Listing on the website of the Hong Kong Stock Exchange on the same day.